CMP Pharma’s CaroSpir, the first FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone, is now available. CaroSpir was approved on August 4.   CaroSpir oral suspension is for adult patients who have difficulty swallowing, or who cannot swallow tablets. It provides a stable and consistent dose of spironolactone. Previously, patients that required a liquid form of spironolactone have had to rely on unapproved pharmacy compounded formulations, which typically have ...